Global Single-use Bioprocessing Market Size By Type (PH Sensor, Valve), By Application (Biotechnology Industry, Pharmaceutical Industry), By Region, And Segment Forecasts, 2023 to 2032

The Global Single-use Bioprocessing Market was valued at USD 12.8 billion in 2023 and is projected to reach USD 34.5 billion by 2031, growing at a robust CAGR of 13.2% during the forecast period (2023–2031). The market's growth is fueled by the increasing adoption of single-use technologies (SUTs) in the biopharmaceutical industry due to their cost-effectiveness, lower risk of cross-contamination, faster process turnaround times, and enhanced flexibility. As the global demand for biologics, vaccines, and personalized medicine rises, single-use bioprocessing has become a cornerstone in modern manufacturing strategies, especially among contract manufacturing organizations (CMOs) and small to mid-sized biotech firms.

Drivers:

1. Surge in Biologics and Vaccine Production:

The growing prevalence of chronic diseases and infectious outbreaks has led to a surge in biologics and vaccine production, driving demand for scalable and efficient bioprocessing systems.

2. Flexibility and Cost Efficiency of SUTs:

Single-use systems reduce cleaning validation requirements and initial capital investment, making them ideal for multiproduct facilities and low-volume productions.

3. Rise in Contract Manufacturing and Outsourcing:

An increasing number of biopharmaceutical companies are outsourcing manufacturing to CMOs, who favor single-use systems for their agility and cost savings.

Restraints:

1. Concerns over Leachables and Extractables:

Chemical leachables from plastic components may contaminate products, raising regulatory and safety concerns.

2. Waste Management Challenges:

The disposable nature of single-use systems contributes to solid waste, which is a growing environmental concern, especially in regions with strict sustainability goals.

Opportunity:

1. Expansion in Emerging Markets:

Biopharma expansion in Asia-Pacific and Latin America is creating lucrative opportunities for single-use system providers due to increasing healthcare investments and local biologics production.

2. Technological Advancements in SUT Materials and Design:

Innovation in polymer science and modular bioprocessing units is enabling better performance, increased scalability, and reduced environmental impact.

Market by System Type Insights:

In 2023, the Single-use Bioreactors segment held the largest market share, driven by their integral role in upstream bioprocessing and widespread adoption for mammalian cell culture. The Single-use Filtration Systems segment is projected to grow at the fastest pace, attributed to the increasing complexity of biologics and demand for effective separation and purification solutions.

Market by End-use Insights:

Biopharmaceutical and Pharmaceutical Companies were the dominant end-use segment in 2023, accounting for over 55% of the market share. These companies are leading adopters of single-use technologies due to their role in drug development pipelines. Contract Manufacturing Organizations (CMOs) are expected to experience the highest growth rate, owing to increasing outsourcing trends and their preference for flexible, cost-effective manufacturing technologies.

Market by Regional Insights:

North America led the market in 2023 due to its strong biopharmaceutical infrastructure, advanced technology adoption, and presence of major industry players. Asia-Pacific is anticipated to witness the highest growth during the forecast period, driven by government incentives, rising biotech investments, and increasing contract manufacturing activity in countries like China, India, and South Korea.

Competitive Scenario:

Prominent players in the Global Single-use Bioprocessing Market include Thermo Fisher Scientific, Sartorius AG, Danaher Corporation (Cytiva), Merck KGaA, Eppendorf AG, Parker Hannifin Corporation, Avantor, Inc., and Saint-Gobain. These companies are focusing on strategic acquisitions, product innovation, and global expansion to enhance their market share.

Key Market Developments:

2023: Sartorius launched a new single-use bioreactor line with integrated automation, designed for high-density cell culture applications.

2024: Thermo Fisher Scientific expanded its single-use production facility in the U.S. to meet growing demand in biologics manufacturing.

2025: Danaher (Cytiva) introduced an AI-enabled modular single-use filtration system to optimize real-time bioprocessing.

Scope of Work – Global Single-use Bioprocessing Market

Report Metric Details

Market Size (2023) USD 12.8 Billion

Projected Market Size (2031) USD 34.5 Billion

CAGR (2023–2031) 13.2%

Market Segments By System Type (Bioreactors, Filtration, Bags, Mixers), By End-use (Biopharmaceutical Companies, CMOs, Academic & Research Institutes), By Region

Growth Drivers Rise in biologics production, cost-efficiency and flexibility of SUTs, increased adoption among CMOs

Opportunities Emerging markets expansion, advancements in disposable material technology

FAQs:

1) What is the current market size of the Global Single-use Bioprocessing Market?

The market was valued at USD 12.8 billion in 2023.

2) What is the major growth driver of the Global Single-use Bioprocessing Market?

The key driver is the increasing adoption of single-use technologies in biologics and vaccine manufacturing due to their flexibility, cost-effectiveness, and scalability.

3) Which is the largest region during the forecast period in the Global Single-use Bioprocessing Market?

North America holds the largest market share, while Asia-Pacific is expected to witness the highest growth.

4) Which segment accounted for the largest market share in the Global Single-use Bioprocessing Market?

The Single-use Bioreactors segment dominated the market in 2023.

5) Who are the key market players in the Global Single-use Bioprocessing Market?

Leading players include Thermo Fisher Scientific, Sartorius AG, Danaher (Cytiva), Merck KGaA, and Eppendorf AG.